Zoledronic acid concurrent with either high- or reduced-dose palliative radiotherapy in the management of the breast cancer patients with bone metastases: a phase IV randomized clinical study

Atahan L., YILDIZ F., CENGİZ M., Kaplan B., ÖZKAN M., YAZICI G., ...More

SUPPORTIVE CARE IN CANCER, vol.18, no.6, pp.691-698, 2010 (SCI-Expanded, Scopus) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 18 Issue: 6
  • Publication Date: 2010
  • Doi Number: 10.1007/s00520-009-0663-x
  • Journal Name: SUPPORTIVE CARE IN CANCER
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.691-698
  • Keywords: Bone metastasis, Breast cancer, Radiotherapy, Zoledronic acid, IN-VITRO, SKELETAL COMPLICATIONS, MULTIFRACTION RADIOTHERAPY, BISPHOSPHONATES INHIBIT, TRIAL, CARCINOMA, CELLS, APOPTOSIS, ADHESION, SINGLE
  • Akdeniz University Affiliated: Yes

Abstract

In this prospective study, the efficacy and safety of radiotherapy combined with zoledronic acid was evaluated.